One of biotech’s biggest conferences grapples with how to talk about race and identity
If you’re trying to explain systemic racism to a group of scientists and biotech professionals, do it in terms they understand.
Racially unjust systems are like “a mutation … in the social DNA,” said Cerevel CEO Tony Coles, speaking on a panel about race and inequality at a now-virtual conference held by the Biotech Innovation Organization, an industry trade group.
